Unternehmen
OLINK PROTEOMICS AB
OLINK PROTEOMICS AB – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception. Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflam…
- Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches The human immune system controls the efficiency to respond to infections and eliminate aberrant cells, such a…